8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)
Published . Updated .
8-K - Milestone Pharmaceuticals filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- MIST Milestone Pharmaceuticals-12.5% 10d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+19.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.5% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+1.0% 17d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MIST | -8.18% | -16.00% | base | +2.23% | -3.42% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| XBINo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001104659-26-119669 Size: 193 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Source: sec-edgar
The price since 28 Oct 2026: Milestone Pharmaceuticals (MIST) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Milestone Pharmaceuticals (MIST) | that day | +2.23% | final price |
| Milestone Pharmaceuticals (MIST) | the next day | -3.42% | final price |
| Milestone Pharmaceuticals (MIST) | three days earlier | -16.00% | final price |
| Milestone Pharmaceuticals (MIST) | five days earlier | -8.18% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 50 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 68 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 70 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Milestone Pharmaceuticals (MIST)
Companies mentioned with this story
- MIST Milestone Pharmaceuticals
Milestone Pharmaceuticals (MIST) is linked, with no stored direction, high confidence in the 28 Oct 2026 story “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> MIST
How “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” reaches Milestone Pharmaceuticals (MIST)
Milestone Pharmaceuticals (MIST) is the company in “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer),” the 28 Oct 2026 this story story.
What ties Milestone Pharmaceuticals (MIST) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> MIST
Dates in the story, and the Milestone Pharmaceuticals (MIST) price range
MIST traded between 0.70 and 0.94 across 10 sessions. The latest close on file is 0.78.
How solid “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” looks
14 out of 100
“8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.